NCT03586999 2024-10-29Nivolumab With Standard of Care Chemotherapy for Peripheral T Cell LymphomasUniversity of Colorado, DenverPhase 1/2 Completed18 enrolled 14 charts
NCT01897571 2024-03-26Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCLIpsenPhase 1/2 Completed400 enrolled 22 charts 3 FDA